Loxo Oncology, Inc. - Common Stock
|Range Today||$85.28 - $87.46|
|52 Week Range||$17.14 - $95.92|
Loxo Oncology, Inc. is a biopharmaceutical company, which develops small molecule therapeutics for the treatment of cancer. Its pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.